EdgarLookup

American National Group Inc. — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that American National Group Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
7.1%
Profit Margin
Net income ÷ revenue
0.4%
Return on Assets
Net income ÷ assets
39.89x
Debt-to-Equity
Total liabilities ÷ equity
-0.4%
Revenue Growth
Year over year

Revenue

Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $7.49B Mar 31, 2026
FY2025 Dec 31, 2024 $7.52B Mar 31, 2026
FY2025 Dec 31, 2023 $3.40B Mar 31, 2026
FY2024 Dec 31, 2022 $2.37B Mar 31, 2025
FY2024 May 24, 2022 $1.66B Mar 31, 2025
FY2023 Dec 31, 2021 $3.69B Feb 29, 2024
FY2020 Dec 31, 2020 $1.03B Mar 1, 2021
FY2020 Sep 30, 2020 $798.71M Mar 1, 2021
FY2020 Jun 30, 2020 $919.95M Mar 1, 2021
FY2020 Mar 31, 2020 ($323.70M) Mar 1, 2021

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $533.00M Mar 31, 2026
FY2025 Dec 31, 2024 $729.00M Mar 31, 2026
FY2025 Dec 31, 2023 $392.00M Mar 31, 2026
FY2024 Dec 31, 2022 $324.00M Mar 31, 2025
FY2024 May 24, 2022 $131.00M Mar 31, 2025
FY2023 Dec 31, 2021 $553.02M Feb 29, 2024
FY2022 Dec 31, 2020 $671.46M Feb 28, 2023
FY2019 Dec 31, 2019 $220.15M Feb 25, 2020
FY2019 Sep 30, 2019 $37.36M Feb 25, 2020
FY2019 Jun 30, 2019 $18.59M Feb 25, 2020

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2024 Dec 31, 2024 $2.52B Mar 31, 2025
FY2024 Dec 31, 2023 $1.19B Mar 31, 2025
FY2024 Dec 31, 2022 $110.00M Mar 31, 2025
FY2024 May 24, 2022 ($123.00M) Mar 31, 2025
FY2023 Dec 31, 2021 $4.23B Feb 29, 2024
FY2022 Dec 31, 2020 $1.30B Feb 28, 2023
FY2021 Dec 31, 2019 $3.35B Mar 1, 2022
FY2020 Dec 31, 2018 $43.19M Mar 1, 2021
FY2019 Dec 31, 2017 $1.92B Feb 25, 2020
FY2018 Dec 31, 2016 $1.42B Feb 22, 2019

Capital Expenditures (Capex)

Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.

Fiscal Year Period End Value Filed
FY2023 Dec 31, 2023 $50.08M Feb 29, 2024
FY2023 Dec 31, 2022 $40.96M Feb 29, 2024
FY2023 Dec 31, 2021 $18.11M Feb 29, 2024
FY2022 Dec 31, 2020 $13.24M Feb 28, 2023
FY2021 Dec 31, 2019 $4.02M Mar 1, 2022
FY2020 Dec 31, 2018 $4.28M Mar 1, 2021
FY2019 Dec 31, 2017 $4.81M Feb 25, 2020
FY2018 Dec 31, 2016 $1.20M Feb 22, 2019
FY2017 Dec 31, 2015 $1.31M Feb 23, 2018
FY2016 Dec 31, 2014 $1.35M Feb 27, 2017

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $130.26B Mar 31, 2026
FY2025 Dec 31, 2024 $121.22B Mar 31, 2026
FY2024 Dec 31, 2023 $35.89B Mar 31, 2025
FY2023 Dec 31, 2022 $73.18B Feb 29, 2024
FY2022 Dec 31, 2021 $78.35B Feb 28, 2023
FY2021 Dec 31, 2020 $71.69B Mar 1, 2022
FY2020 Dec 31, 2019 $69.70B Mar 1, 2021
FY2019 Dec 31, 2018 $61.63B Feb 25, 2020
FY2018 Dec 31, 2017 $62.03B Feb 22, 2019
FY2017 Dec 31, 2016 $56.05B Feb 23, 2018

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $120.59B Mar 31, 2026
FY2025 Dec 31, 2024 $111.19B Mar 31, 2026
FY2024 Dec 31, 2023 $29.99B Mar 31, 2025
FY2023 Dec 31, 2022 $70.81B Feb 29, 2024
FY2022 Dec 31, 2021 $72.03B Feb 28, 2023
FY2021 Dec 31, 2020 $65.34B Mar 1, 2022
FY2020 Dec 31, 2019 $65.13B Mar 1, 2021
FY2019 Dec 31, 2018 $59.23B Feb 25, 2020
FY2018 Dec 31, 2017 $59.18B Feb 22, 2019
FY2017 Dec 31, 2016 $53.76B Feb 23, 2018

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2023 Dec 31, 2023 $3.02B Feb 29, 2024
FY2023 Dec 31, 2022 $2.35B Feb 29, 2024
FY2022 Dec 31, 2021 $6.32B Feb 28, 2023
FY2021 Dec 31, 2020 $6.35B Mar 1, 2022
FY2021 Dec 31, 2019 $4.43B Mar 1, 2022
FY2021 Dec 31, 2018 $2.40B Mar 1, 2022
FY2020 Dec 31, 2017 $2.85B Mar 1, 2021
FY2019 Dec 31, 2016 $2.29B Feb 25, 2020
FY2018 Dec 31, 2015 $1.94B Feb 22, 2019
FY2017 Dec 31, 2014 $2.14B Feb 23, 2018

Goodwill

An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $748.00M Mar 31, 2026
FY2025 Dec 31, 2024 $748.00M Mar 31, 2026
FY2025 Dec 31, 2023 $86.00M Mar 31, 2026
FY2025 Dec 31, 2022 $86.00M Mar 31, 2026
FY2024 May 25, 2022 $0 Mar 31, 2025
FY2024 May 24, 2022 $44.00M Mar 31, 2025
FY2024 Dec 31, 2021 $44.00M Mar 31, 2025

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $1.76B Mar 31, 2026
FY2025 Dec 31, 2024 $1.36B Mar 31, 2026
FY2024 Dec 31, 2023 $716.00M Mar 31, 2025
FY2023 Dec 31, 2022 $4.69B Feb 29, 2024
FY2022 Dec 31, 2021 $2.77B Feb 28, 2023
FY2021 Dec 31, 2020 $2.37B Mar 1, 2022
FY2020 Dec 31, 2019 $1.77B Mar 1, 2021
FY2019 Dec 31, 2018 $1.55B Feb 25, 2020
FY2018 Dec 31, 2017 $1.24B Feb 22, 2019
FY2017 Dec 31, 2016 $1.09B Feb 23, 2018

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $11.66B Mar 31, 2026
FY2025 Dec 31, 2024 $10.87B Mar 31, 2026
FY2024 Dec 31, 2023 $3.19B Mar 31, 2025
FY2023 Dec 31, 2022 $1.92B Feb 29, 2024
FY2022 Dec 31, 2021 $4.51B Feb 28, 2023
FY2021 Dec 31, 2020 $9.10B Mar 1, 2022
FY2021 Dec 31, 2019 $2.29B Mar 1, 2022
FY2021 Dec 31, 2018 $344.40M Mar 1, 2022
FY2020 Dec 31, 2017 $1.43B Mar 1, 2021
FY2019 Dec 31, 2016 $791.27M Feb 25, 2020

Long-Term Debt

Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $2.95B Mar 31, 2026
FY2025 Dec 31, 2024 $2.96B Mar 31, 2026
FY2024 Dec 31, 2023 $1.49B Mar 31, 2025

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2023 Dec 31, 2023 2 Feb 29, 2024
FY2023 Dec 31, 2022 20 Feb 29, 2024
FY2023 Dec 31, 2021 5 Feb 29, 2024
FY2020 Dec 31, 2020 0 Mar 1, 2021
FY2020 Sep 30, 2020 7 Mar 1, 2021
FY2020 Jun 30, 2020 (2) Mar 1, 2021
FY2020 Mar 31, 2020 2 Mar 1, 2021
FY2020 Dec 31, 2019 2 Mar 1, 2021
FY2020 Sep 30, 2019 0 Mar 1, 2021
FY2020 Jun 30, 2019 0 Mar 1, 2021

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2023 Dec 31, 2023 2 Feb 29, 2024
FY2023 Dec 31, 2022 20 Feb 29, 2024
FY2023 Dec 31, 2021 5 Feb 29, 2024
FY2020 Dec 31, 2020 0 Mar 1, 2021
FY2020 Sep 30, 2020 7 Mar 1, 2021
FY2020 Jun 30, 2020 (2) Mar 1, 2021
FY2020 Mar 31, 2020 2 Mar 1, 2021
FY2020 Dec 31, 2019 2 Mar 1, 2021
FY2020 Sep 30, 2019 0 Mar 1, 2021
FY2020 Jun 30, 2019 0 Mar 1, 2021

Shares Outstanding

Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.

Fiscal Year Period End Value Filed
FY2025 May 2, 2024 10,000 Mar 31, 2026
FY2023 Dec 31, 2023 79.34M Feb 29, 2024
FY2023 Dec 31, 2022 84.81M Feb 29, 2024
FY2022 Dec 31, 2021 92.51M Feb 28, 2023
FY2021 Dec 31, 2020 95.72M Mar 1, 2022
FY2020 Dec 31, 2019 91.11M Mar 1, 2021
FY2019 Dec 31, 2018 90.37M Feb 25, 2020
FY2018 Dec 31, 2017 89.33M Feb 22, 2019
FY2017 Dec 31, 2016 88.00M Feb 23, 2018
FY2016 Dec 31, 2015 81.35M Feb 27, 2017

Dividends Paid

Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.

Fiscal Year Period End Value Filed
FY2023 Dec 31, 2023 $0 Feb 29, 2024
FY2023 Dec 31, 2022 $30.21M Feb 29, 2024
FY2023 Dec 31, 2021 $31.45M Feb 29, 2024
FY2022 Dec 31, 2020 $28.86M Feb 28, 2023
FY2021 Dec 31, 2019 $27.30M Mar 1, 2022
FY2020 Dec 31, 2018 $25.27M Mar 1, 2021
FY2019 Dec 31, 2017 $23.15M Feb 25, 2020
FY2018 Dec 31, 2016 $21.11M Feb 22, 2019
FY2017 Dec 31, 2015 $17.87M Feb 23, 2018
FY2016 Dec 31, 2014 $15.02M Feb 27, 2017